jueves, 11 de febrero de 2021

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial - The Lancet Respiratory Medicine

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario